Skip to content

Clinical trials

Phase 3 Sleep Initiation and Maintenance Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sleep Initiation and Maintenance Disorders Phase: Phase 3 Country / region: United States Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20024
20035
20049
20057
20067
20079
20082
20094
20111
20121
20131
20163
20171
20184
20193
20211
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Terminated6
Recruiting4
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi10
Takeda9
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.8
Sumitomo Pharma America, Inc.6
Eisai Inc.3
Idorsia Pharmaceuticals Ltd.3
Vanda Pharmaceuticals3
University of Pennsylvania2
Axsome Therapeutics, Inc.1
Biogen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sleep Initiation and Maintenance Disorders67
Parasomnias6
Sleep Wake Disorders6
Attention Deficit Disorder with Hyperactivity3
Major Depressive Disorder3
Bipolar Disorder2
Disorders of Excessive Somnolence2
Sleep Disorders, Circadian Rhythm2
Substance-Related Disorders2
Alcoholism1

Trials

Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.